SCHEMBL3580888

SCHEMBL3580888

N#Cc1c(N)nc(S)c(C#N)c1C1CCC(O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 2/20 0.43
GALR3 O60755 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
GAA P10253 4/20 0.34
CHUK O15111 1/20 0.33
IKBKB O14920 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3580885 1.00 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL29658478 0.92 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL19716904 0.92 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL3576011 0.84 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL3570759 0.82 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL3577618 0.81 ALDH1A1 (0.38) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL3578260 0.75 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL3574454 0.75 MEN1 (0.43) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL3574209 0.75 ALDH1A1 (0.36) ALDH1A1MEN1KMT2AMAPTGALR3
SCHEMBL3847944 0.74 CYP1A2 (0.35) ALDH1A1MEN1KMT2AMAPTGALR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099788-B1 CYCLICALLY SUBSTITUTED 3,5-DICYANO-2-THIOPYRIDINES AND USE THEREOF BAYER IP GMBH (DE) 2013-03-06 EP disclosed
US-8304412-B2 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-11-06 US disclosed
US-20100022544-A1 CYCLICALLY SUBSTITUTED 3,5-DICYANO-2-THIOPYRIDINES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022544-A1 CYCLICALLY SUBSTITUTED 3,5-DICYANO-2-THIOPYRIDINES AND USE THEREOF QDPR, TPMT, PTGIS ALDH1A1 2199/4885MEN1 3404/4885KMT2A 3508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.